CSWC · Capital Southwest Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.66M | $1.70M | $1.67M | $1.57M | $1.64M | $1.48M | $1.22M | $1.30M | $1.33M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $1.68M | - | - | $1.28M | - | - | $651.0K | - | - | - |
| Operating Income | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | - | - | - | $12.45M | - | - | $9.68M | $11.47M | $10.48M | - |
| Income Tax | $828.0K | ($2.35M) | $2.03M | $2.43M | $367.0K | ($783.0K) | - | - | - | - |
| Net Income | $27.00M | $32.90M | $25.62M | $14.04M | $16.27M | $22.68M | $23.81M | $23.48M | $22.62M | - |
| EPS - Basic | $0.50 | $0.57 | $0.46 | $0.63 | $0.63 | $0.66 | $0.65 | $0.70 | $0.69 | - |
| EPS - Diluted | $0.48 | $0.34 | $0.44 | $0.63 | - | $0.66 | $0.65 | $0.70 | $0.69 | - |
Balance Sheet
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29.05M | $42.56M | $87.43M | $43.22M | $36.01M | $47.24M | $32.27M | $23.61M | $23.02M | $21.59M |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $2.18B | $2.12B | $2.02B | $1.88B | $1.79B | $1.60B | $1.56B | $1.43B | $1.42B | $1.26B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $1.13B | $1.07B | $1.03B | $956.07M | $920.19M | $785.03M | $770.85M | $677.84M | $732.67M | $637.64M |
| Total Liabilities | $1.17B | $1.12B | $1.07B | $999.21M | $958.62M | $813.24M | $801.08M | $708.52M | $759.14M | $667.28M |
| Stockholders' Equity | $1.01B | $995.63M | $947.00M | $883.63M | $830.44M | $791.26M | $755.68M | $720.97M | $657.77M | $590.41M |
| Retained Earnings | ($79.01M) | ($76.45M) | ($107.48M) | ($88.72M) | ($85.58M) | ($75.84M) | ($52.53M) | ($41.19M) | ($43.09M) | ($41.84M) |
Cash Flow
| Line item | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $30.49M | - | - | $31.13M | - | - | ($55.63M) | - | - | - |
| Investing Cash Flow | ($141.0K) | - | - | ($25.0K) | - | - | ($156.0K) | - | - | - |
| Financing Cash Flow | ($26.68M) | - | - | ($30.07M) | - | - | $55.32M | - | - | - |
| CapEx | $141.0K | - | - | $25.0K | - | - | $2.0K | - | - | - |
| Free Cash Flow | $30.35M | - | - | $31.10M | - | - | ($55.63M) | - | - | - |
Ratios
| Metric | Q1 '26 | Q3 '26 | Q2 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 1.12 | - | - | 2.22 | - | - | -2.34 | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 3.0% | -7.7% | 7.4% | 14.7% | 2.2% | -3.6% | - | - | - | - |
| Return on assets | 1.2% | 1.6% | 1.3% | 0.7% | 0.9% | 1.4% | 1.5% | 1.6% | 1.6% | - |
| Return on equity | 2.7% | 3.3% | 2.7% | 1.6% | 2.0% | 2.9% | 3.2% | 3.3% | 3.4% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 1.12 | 1.08 | 1.09 | 1.08 | 1.11 | 0.99 | 1.02 | 0.94 | 1.11 | 1.08 |
| Debt / Assets | 0.52 | 0.51 | 0.51 | 0.51 | 0.51 | 0.49 | 0.50 | 0.47 | 0.52 | 0.51 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.15 | 2.13 | 2.13 | 2.13 | 2.15 | 2.03 | 2.06 | 1.98 | 2.15 | 2.13 |
| Liabilities / Assets | 0.54 | 0.53 | 0.53 | 0.53 | 0.54 | 0.51 | 0.51 | 0.50 | 0.54 | 0.53 |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 46.1x | 65.1x | 49.7x | 35.4x | - | 38.3x | 38.4x | 33.9x | 33.2x | - |
| P / B | 1.4x | 1.5x | 1.5x | 1.2x | 1.4x | 1.5x | 1.2x | 1.4x | 1.4x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | 92.4% | 102.2% | 12.9% | -41.1% | -30.7% | 0.3% | - | 696.3% | 139.2% | - |
| EPS growth (YoY) | -23.8% | - | -33.3% | -3.1% | - | -4.3% | - | 37.3% | 60.5% | - |
| EPS CAGR (3y) | - | -12.6% | 0.8% | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -2.4% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 14.4% | 19.9% | 19.7% | 16.9% | 15.2% | 20.3% | 28.0% | 28.4% | 72.2% | - |
Dividends
$2.94/share trailing 12 months · +15.9% YoY
| Ex-date | Per share |
|---|---|
| May 15, 2026 | $0.1930 |
| Apr 15, 2026 | $0.1930 |
| Mar 13, 2026 | $0.2530 |
| Feb 13, 2026 | $0.1930 |
| Jan 15, 2026 | $0.1930 |
| Dec 15, 2025 | $0.2530 |
| Nov 14, 2025 | $0.1930 |
| Oct 15, 2025 | $0.1930 |
| Sep 15, 2025 | $0.2530 |
| Aug 15, 2025 | $0.1930 |
| Jul 15, 2025 | $0.1930 |
| Jun 13, 2025 | $0.6400 |
| Mar 14, 2025 | $0.6400 |
| Dec 13, 2024 | $0.6300 |
| Sep 13, 2024 | $0.6400 |
| Jun 14, 2024 | $0.6300 |
| Mar 14, 2024 | $0.6300 |
| Dec 14, 2023 | $0.6300 |
| Sep 14, 2023 | $0.6200 |
| Jun 14, 2023 | $0.5900 |
| Mar 14, 2023 | $0.5800 |
| Dec 14, 2022 | $0.5700 |
| Sep 14, 2022 | $0.5000 |
| Jun 14, 2022 | $0.6300 |